1373 related articles for article (PubMed ID: 28887948)
1. Psoriasis pathogenesis and the development of novel targeted immune therapies.
Hawkes JE; Chan TC; Krueger JG
J Allergy Clin Immunol; 2017 Sep; 140(3):645-653. PubMed ID: 28887948
[TBL] [Abstract][Full Text] [Related]
2. Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.
Hawkes JE; Yan BY; Chan TC; Krueger JG
J Immunol; 2018 Sep; 201(6):1605-1613. PubMed ID: 30181299
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of emerging immunotherapies in psoriasis.
Yiu ZZ; Warren RB
Immunotherapy; 2015; 7(2):119-33. PubMed ID: 25713988
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.
Jeon C; Sekhon S; Yan D; Afifi L; Nakamura M; Bhutani T
Hum Vaccin Immunother; 2017 Oct; 13(10):2247-2259. PubMed ID: 28825875
[TBL] [Abstract][Full Text] [Related]
5. The role of IL 23 in the treatment of psoriasis.
Puig L
Expert Rev Clin Immunol; 2017 Jun; 13(6):525-534. PubMed ID: 28165883
[TBL] [Abstract][Full Text] [Related]
6. New biologics in psoriasis: an update on IL-23 and IL-17 inhibitors.
Dong J; Goldenberg G
Cutis; 2017 Feb; 99(2):123-127. PubMed ID: 28319618
[TBL] [Abstract][Full Text] [Related]
7. Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study.
Torres T; Puig L; Vender R; Yeung J; Carrascosa JM; Piaserico S; Gisondi P; Lynde C; Ferreira P; Bastos PM; Dauden E; Leite L; Valerio J; Del Alcázar-Viladomiu E; Rull EV; Llamas-Velasco M; Pirro F; Messina F; Bruni M; Licata G; Ricceri F; Nidegger A; Hugo J; Mufti A; Daponte AI; Teixeira L; Balato A; Romanelli M; Prignano F; Gkalpakiotis S; Conrad C; Lazaridou E; Rompoti N; Papoutsaki M; Nogueira M; Chiricozzi A
Am J Clin Dermatol; 2022 Nov; 23(6):891-904. PubMed ID: 35976568
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
Chiricozzi A
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():9-20. PubMed ID: 25398488
[TBL] [Abstract][Full Text] [Related]
9. Anti IL-17 in psoriasis.
Ly K; Smith MP; Thibodeaux Q; Reddy V; Liao W; Bhutani T
Expert Rev Clin Immunol; 2019 Nov; 15(11):1185-1194. PubMed ID: 31603358
[No Abstract] [Full Text] [Related]
10. IL-17 targeted therapies for psoriasis.
Chiricozzi A; Krueger JG
Expert Opin Investig Drugs; 2013 Aug; 22(8):993-1005. PubMed ID: 23731078
[TBL] [Abstract][Full Text] [Related]
11. State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis.
Gisondi P; Geat D; Pizzolato M; Girolomoni G
Curr Opin Pharmacol; 2019 Jun; 46():90-99. PubMed ID: 31212119
[TBL] [Abstract][Full Text] [Related]
12. Novel Biologic Agents Targeting Interleukin-23 and Interleukin-17 for Moderate-to-Severe Psoriasis.
Chen Z; Gong Y; Shi Y
Clin Drug Investig; 2017 Oct; 37(10):891-899. PubMed ID: 28755058
[TBL] [Abstract][Full Text] [Related]
13. Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis.
Sakkas LI; Zafiriou E; Bogdanos DP
Front Pharmacol; 2019; 10():872. PubMed ID: 31447673
[TBL] [Abstract][Full Text] [Related]
14. Next-generation biologics in the management of plaque psoriasis: a literature review of IL-17 inhibition.
Yamauchi PS; Bagel J
J Drugs Dermatol; 2015 Mar; 14(3):244-53. PubMed ID: 25738846
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
Mease PJ
Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
[TBL] [Abstract][Full Text] [Related]
17. A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
Tonini A; Gualtieri B; Panduri S; Romanelli M; Chiricozzi A
Expert Opin Biol Ther; 2018 Feb; 18(2):135-148. PubMed ID: 29103330
[TBL] [Abstract][Full Text] [Related]
18. The plot thickens while the scope broadens: a holistic view on IL-17 in psoriasis and other inflammatory disorders.
Schön MP
Exp Dermatol; 2014 Nov; 23(11):804-6. PubMed ID: 25219805
[TBL] [Abstract][Full Text] [Related]
19. The role of IL-17 in psoriasis.
Malakouti M; Brown GE; Wang E; Koo J; Levin EC
J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 and innate immunity in infections and chronic inflammation.
Isailovic N; Daigo K; Mantovani A; Selmi C
J Autoimmun; 2015 Jun; 60():1-11. PubMed ID: 25998834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]